 Lilly says the drug, given as a monthly infusion, will cost $32,000 for a year of treatment. That's a little more than an older, similar drug called Lekembe, which has to be taken every two weeks indefinitely. Sydney Lufkin, NPR News. Stocks gain ground on Wall Street after better-than-expected sales from electric vehicle maker Tesla and some indications inflation continues to ease. The Dow is up 162 points. The Nasdaq rose 149 points. You're listening to NPR.